Evidence map›Paper›PMID 11483765›Full record

ArticleJournal of virology2001

Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy.

B R Lane, K Lore, P J Bock, J Andersson, M J Coffey, R M Strieter, D M Markovitz

Abstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Circulation · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Current genomics · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B R LaneDivisions of Infectious Diseases, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0640, USA.
K Lore
P J Bock
J Andersson
M J Coffey
R M Strieter
D M Markovitz

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENFIRE, MELVYN · 1985 to 2007
$40.8M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
REGULATION OF HIV2 TRANSCRIPTION BY THE PETS FACTORR01AI036685 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARKOVITZ, DAVID MICHAEL · 1994 to 2002
$929k
CHEMOKINES AND HIV REPLICATION IN ALVEOLAR MACROPHAGESR01HL057885 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COFFEY, MICHAEL J · 1996 to 2000
$305k
NCRR NIH HHS M01 RR000042NCRR NIH HHS M01-RR00042NHLBI NIH HHS HL57885NIAID NIH HHS AI07528NIAID NIH HHS AI36685NIAID NIH HHS T32 AI007528NIGMS NIH HHS GM07315NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM007863NIGMS NIH HHS T32 GM07863
6 · The paper itself

Abstract

Production of the C-X-C chemokines interleukin-8 (IL-8) and growth-regulated oncogene alpha (GRO-alpha) in macrophages is stimulated by exposure to human immunodeficiency virus type 1 (HIV-1). We have demonstrated previously that GRO-alpha then stimulates HIV-1 replication in both T lymphocytes and macrophages. Here we demonstrate that IL-8 also stimulates HIV-1 replication in macrophages and T lymphocytes. We further show that increased levels of IL-8 are present in the lymphoid tissue of patients with AIDS. In addition, we demonstrate that compounds which inhibit the actions of IL-8 and GRO-alpha via their receptors, CXCR1 and CXCR2, also inhibit HIV-1 replication in both T lymphocytes and macrophages, indicating potential therapeutic uses for these compounds in HIV-1 infection and AIDS.

Indexed as

Chemokines, CXCIntercellular Signaling Peptides and ProteinsAcquired Immunodeficiency SyndromeAntibodiesChemokine CXCL1Chemotactic FactorsGrowth SubstancesHIV-1HumansInterleukin-8Lymphoid TissueMacrophagesMonocytesPhenylurea CompoundsReceptors, Interleukin-8AReceptors, Interleukin-8BAntibodiesChemokine CXCL1Chemokines, CXCChemotactic FactorsCXCL1 protein, humanGrowth SubstancesIntercellular Signaling Peptides and ProteinsInterleukin-8Phenylurea CompoundsReceptors, Interleukin-8AReceptors, Interleukin-8BSB 225002

Identifiers

PMID11483765
PMCPMC115064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.